July 22, 2025 a 07:43 pm
ZTS: Fundamental Ratio Analysis - Zoetis Inc.
Zoetis Inc., a leader in animal health, demonstrates a solid fundamental profile with potential for growth. Despite challenges in the global market, the company's diversified product offering and international presence provide a robust foundation. Recent analysis indicates a stable financial health, appealing to cautious investors.
Fundamental Rating
The recent fundamental analysis highlights a balanced performance with strong returns on equity and assets. However, some aspects like debt-to-equity and price-to-book ratios remain areas to watch. Overall, Zoetis stands strong in its sector.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 1 | |
| Price To Earnings | 2 | |
| Price To Book | 1 |
Historical Rating
Comparing past and present data reveals consistency in key financial metrics. Nevertheless, there are minor fluctuations that potential investors should consider.
| Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-22 | 3 | 4 | 5 | 5 | 1 | 2 | 1 |
| Previous | 0 | 4 | 5 | 5 | 1 | 2 | 1 |
Analyst Price Targets
Analysts suggest a promising price range, with the median target reflecting cautious optimism in market performance. The consensus remains positive, advocating a 'Buy' status.
| High | Low | Median | Consensus |
|---|---|---|---|
| $243 | $160 | $170 | $191 |
Analyst Sentiment
Market sentiment from analysts remains favorable, with a substantial number of 'Buy' recommendations, reinforcing the stock’s potential value.
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 16 | |
| Hold | 12 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Zoetis Inc., with its strong market presence and diversified offerings, shows resilience and potential for growth in the animal health sector. The company's current financial metrics are promising, with substantial returns on equity and assets while maintaining a manageable debt profile. While the stock is predominantly considered a 'Buy,' investors should monitor areas requiring attention, such as debt and valuation ratios. Overall, Zoetis remains a compelling choice for those looking to invest in healthcare innovation and sustainability.